Publicaciones en colaboración con investigadores/as de University of Milan (29)

2024

  1. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

    Kidney International Reports, Vol. 9, Núm. 6, pp. 1817-1835

  2. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

2023

  1. High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome

    Journal of Autoimmunity

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 8, pp. 1550-1561

  2. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  3. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  4. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

    Scientific Reports, Vol. 10, Núm. 1

  2. Standardization procedure for flow cytometry data harmonization in prospective multicenter studies

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11

2017

  1. Transancestral mapping and genetic load in systemic lupus erythematosus

    Nature Communications, Vol. 8

2013

  1. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci

    Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029

  2. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 602-607

  3. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238

2012

  1. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

    Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 264-271

  2. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

    Arthritis Research and Therapy, Vol. 14, Núm. 3

  3. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis

    Genes and Immunity, Vol. 13, Núm. 6, pp. 458-460

  4. Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up

    Human Molecular Genetics, Vol. 21, Núm. 12, pp. 2825-2835

  5. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression

    Journal of Rheumatology, Vol. 39, Núm. 1, pp. 112-118